-
1
-
-
33645737208
-
WHO analysis of causes of maternal death: A systematic review
-
10.1016/S0140-6736(06)68397-9. 16581405
-
WHO analysis of causes of maternal death: a systematic review. KS Khan D Wojdyla L Say AM Gulmezoglu PF Van Look, Lancet 2006 367 1066 1074 10.1016/S0140-6736(06)68397-9 16581405
-
(2006)
Lancet
, vol.367
, pp. 1066-1074
-
-
Khan, K.S.1
Wojdyla, D.2
Say, L.3
Gulmezoglu, A.M.4
Van Look, P.F.5
-
2
-
-
0036052506
-
A ten year review of maternal mortality in Sokoto, Northern Nigeria
-
12081352
-
A ten year review of maternal mortality in Sokoto, Northern Nigeria. LR Audu BA Ekele, West Afr J Med 2002 21 74 76 12081352
-
(2002)
West Afr J Med
, vol.21
, pp. 74-76
-
-
Audu, L.R.1
Ekele, B.A.2
-
3
-
-
1242297658
-
The analysis of eclamptic morbidity and mortality in Specialist Hospital Gombe, Nigeria
-
10.1080/01443610410001645415.001
-
The analysis of eclamptic morbidity and mortality in Specialist Hospital Gombe, Nigeria. AU El-Nafaty GS Melah AH Massa BM Audu M Nelda, Journal of Obstetrics and Gynaecology 2000 24 2 142 147 10.1080/01443610410001645415.001
-
(2000)
Journal of Obstetrics and Gynaecology
, vol.24
, Issue.2
, pp. 142-147
-
-
El-Nafaty, A.U.1
Melah, G.S.2
Massa, A.H.3
Audu, B.M.4
Nelda, M.5
-
4
-
-
43549096890
-
Pattern of eclampsia in a tertiary health facility in a semi-rural town in northern Nigeria
-
18354940
-
Pattern of eclampsia in a tertiary health facility in a semi-rural town in northern Nigeria. J Tukur BA Umar A Rabi'u, Ann Afr Med 2007 6 4 164 167 18354940
-
(2007)
Ann Afr Med
, vol.6
, Issue.4
, pp. 164-167
-
-
Tukur, J.1
Umar, B.A.2
Rabi'U, A.3
-
5
-
-
0029004929
-
Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial
-
7769899, Eclampsia Trial Collaborative Group
-
Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Eclampsia Trial Collaborative Group, Lancet 1995 345 1455 1463 7769899
-
(1995)
Lancet
, vol.345
, pp. 1455-1463
-
-
-
6
-
-
39649092967
-
Reducing eclampsia related deaths-a clarion call to action
-
10.1016/S0140-6736(08)60321-9. 18313488
-
Reducing eclampsia related deaths-a clarion call to action. A Langer J Villar K Tell T Kim S Kennedy, Lancet 2008 371 705 706 10.1016/S0140-6736(08) 60321-9 18313488
-
(2008)
Lancet
, vol.371
, pp. 705-706
-
-
Langer, A.1
Villar, J.2
Tell, K.3
Kim, T.4
Kennedy, S.5
-
7
-
-
0017859376
-
Problems encountered in the treatment of pregnancy induced hypertension
-
686045
-
Problems encountered in the treatment of pregnancy induced hypertension. SP Zuspan, Am J Obstet Gynecol 1978 131 591 597 686045
-
(1978)
Am J Obstet Gynecol
, vol.131
, pp. 591-597
-
-
Zuspan, S.P.1
-
8
-
-
0021245779
-
The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases
-
6711634
-
The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. JA Pritchard FG Cunningham SA Pritchard, Am J Obstet Gynecol 1984 148 951 963 6711634
-
(1984)
Am J Obstet Gynecol
, vol.148
, pp. 951-963
-
-
Pritchard, J.A.1
Cunningham, F.G.2
Pritchard, S.A.3
-
9
-
-
0021965843
-
Magnesium ions block an N-methyl-D-Aspartate receptor mediated component of synaptic transmission in rat hippocampus
-
10.1016/0304-3940(85)90091-6. 2859558
-
Magnesium ions block an N-methyl-D-Aspartate receptor mediated component of synaptic transmission in rat hippocampus. EJ Coan GL Collingridge, Neurosci Lett 1985 53 21 26 10.1016/0304-3940(85)90091-6 2859558
-
(1985)
Neurosci Lett
, vol.53
, pp. 21-26
-
-
Coan, E.J.1
Collingridge, G.L.2
-
10
-
-
0023212633
-
Cerebral vasoconstriction in toxaemia
-
Cerebral vasoconstriction in toxaemia. AD Will KL Lewis DB Hinshaw Jr K Jordan LM Cousins AN Hasso JR Thompson, Neurology 1987 32 1555 1557
-
(1987)
Neurology
, vol.32
, pp. 1555-1557
-
-
Will, A.D.1
Lewis, K.L.2
Hinshaw Jr, D.B.3
Jordan, K.4
Cousins, L.M.5
Hasso, A.N.6
Thompson, J.R.7
-
11
-
-
26244433268
-
System and market failures: The unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe
-
10.1136/bmj.331.7519.765. 16195297
-
System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. E Sevene S Lewin A Mariano G Woelk AD Oxman S Matinhure J Cliff B Fernandes K Daniels, BMJ 2005 331 7519 765 769 10.1136/bmj.331.7519.765 16195297
-
(2005)
BMJ
, vol.331
, Issue.7519
, pp. 765-769
-
-
Sevene, E.1
Lewin, S.2
Mariano, A.3
Woelk, G.4
Oxman, A.D.5
Matinhure, S.6
Cliff, J.7
Fernandes, B.8
Daniels, K.9
-
12
-
-
0035168785
-
A low dose (Dhaka) magnesium sulphate regime for eclampsia
-
10.1034/j.1600-0412.2001.801105.x. 11703195
-
A low dose (Dhaka) magnesium sulphate regime for eclampsia. R Begum A Begum R Johanson MN Ali S Akhter, Acta Obstet Gynecol Scand 2001 80 11 998 1002 10.1034/j.1600-0412.2001.801105.x 11703195
-
(2001)
Acta Obstet Gynecol Scand
, vol.80
, Issue.11
, pp. 998-1002
-
-
Begum, R.1
Begum, A.2
Johanson, R.3
Ali, M.N.4
Akhter, S.5
-
14
-
-
34247145513
-
Safety and efficacy of low-dose MgSO4 in the treatment of eclampsia
-
10.1016/j.ijgo.2007.01.008. 17368649
-
Safety and efficacy of low-dose MgSO4 in the treatment of eclampsia. Shilva SC Saha J Kalra R Prasad, Int J Gynaecol Obstet 2007 97 150 151 10.1016/j.ijgo.2007.01.008 17368649
-
(2007)
Int J Gynaecol Obstet
, vol.97
, pp. 150-151
-
-
Silva, S.C.1
Saha, J.2
Kalra, R.3
Prasad4
-
15
-
-
57449086562
-
New and underutilized technologies to reduce maternal mortality and morbidity: What progress have we made since Bellagio 2003?
-
10.1111/j.1471-0528.2008.02046.x. 19076957
-
New and underutilized technologies to reduce maternal mortality and morbidity: what progress have we made since Bellagio 2003? VD Tsu PS Coffey, BJOG 2009 116 247 256 10.1111/j.1471-0528.2008.02046.x 19076957
-
(2009)
BJOG
, vol.116
, pp. 247-256
-
-
Tsu, V.D.1
Coffey, P.S.2
-
17
-
-
0035436886
-
Risk factors in Mozambican women with Eclampsia: A case-referent study
-
10.2307/3583428
-
Risk factors in Mozambican women with Eclampsia: A case-referent study. A Bugalho A Bacci S Bergstrom, Afr J Repro Health 2001 5 2 30 35 10.2307/3583428
-
(2001)
Afr J Repro Health
, vol.5
, Issue.2
, pp. 30-35
-
-
Bugalho, A.1
Bacci, A.2
Bergstrom, S.3
-
19
-
-
0036592574
-
Loading dose versus standard regime of magnesium sulphate in the management of eclampsia: A randomized trial
-
10.1046/j.1341-8076.2002.00029.x. 12214831
-
Loading dose versus standard regime of magnesium sulphate in the management of eclampsia: a randomized trial. MR Begum A Begum E Quadir, J Obstet Gynaecol Res 2002 28 3 154 159 10.1046/j.1341-8076.2002.00029.x 12214831
-
(2002)
J Obstet Gynaecol Res
, vol.28
, Issue.3
, pp. 154-159
-
-
Begum, M.R.1
Begum, A.2
Quadir, E.3
-
20
-
-
0142089034
-
The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: Do body mass index alterations have any effect on success?
-
10.1081/PRG-120024029. 14572362
-
The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success? V Dayicioglu Z Sahinoglu E Kol M Kucukbas, Hypertens Pregnancy 2003 22 3 257 65 10.1081/PRG-120024029 14572362
-
(2003)
Hypertens Pregnancy
, vol.22
, Issue.3
, pp. 257-65
-
-
Dayicioglu, V.1
Sahinoglu, Z.2
Kol, E.3
Kucukbas, M.4
-
21
-
-
43049180076
-
Critical care management of eclamptics: Challenges in an African setting
-
10.1258/td.2007.053260
-
Critical care management of eclamptics: challenges in an African setting. UV Okafor RE Efetie, Trop Doctor 2008 38 11 13 10.1258/td.2007.053260
-
(2008)
Trop Doctor
, vol.38
, pp. 11-13
-
-
Okafor, U.V.1
Efetie, R.E.2
-
22
-
-
0034279034
-
Magnesium sulphate for treatment of eclampsia: The Nigerian experience
-
11713998
-
Magnesium sulphate for treatment of eclampsia: the Nigerian experience. IF Adewole A Oladokun AI Okewole AO Omigbodun A Afolabi BA Ekele LR Audu Y Obed, Afr J Med med Sci 2000 29 239 241 11713998
-
(2000)
Afr J Med Med Sci
, vol.29
, pp. 239-241
-
-
Adewole, I.F.1
Oladokun, A.2
Okewole, A.I.3
Omigbodun, A.O.4
Afolabi, A.5
Ekele, B.A.6
Audu, L.R.7
Obed, Y.8
|